Release Date: 25/11/11 19:36 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 98.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%